WHO ICTRP trial
Elucidation of Changes in Plasma Concentration and Protein Binding Ratio of…
JPRN-UMIN000060265 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000060265 |
|---|---|
| Public title | Elucidation of Changes in Plasma Concentration and Protein Binding Ratio of Propofol during Co-administration with Remimazolam |
| Scientific title | Elucidation of Changes in Plasma Concentration and Protein Binding Ratio of Propofol during Co-administration with Remimazolam - Elucidation of Changes in Plasma Concentration and Protein Binding Ratio of Propofol during Co-administration with Remimazolam |
| Primary sponsor | Hamamatsu University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | general anesthesia |
| Interventions | Co-administration of remimazola |
| Registration date | Jun 1, 2026 |
| Target size | 15 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: